COVID-19 Updates

  • Recorded webinar: Get to know VIDO. Get your questions answered.

    Recording of the Saskatchewan Blue Cross Ask a Scientist event. Dr. Volker Gerdts, CEO & Director of VIDO, answers questions about how vaccines are made, how vaccines work, COVID 19 and more!

  • Government of Canada biomanufacturing video series: VIDO

    Find out about VIDO's COVID-19 research and vaccine development and its new Good Manufacturing Practices (GMP) facility.

  • Preventing the next pandemic

    COVID-19 and the escalation of variants of concern underline the fact that emerging diseases require a rapid response, and Canada needs to be prepared for the next pandemic, says Dr. Volker Gerdts, director and CEO of VIDO.

  • Funding announcement and roundtable discussion: finishing the fight against COVID-19

    In a special online, live event, held April 23, the Honourable François-Philippe Champagne, the Honourable Mélanie Joly, and the Honourable Jim Carr, met with representatives from USask and VIDO.

  • Bacon & Eggheads webinar featuring Dr. Volker Gerdts

    This presentation provides an overview of some of the lessons learned from the current pandemic and provide possible solutions of how Canada can be better prepared for emerging diseases.

  • Video: Dr. Alyson Kelvin's COVID-19 research at VIDO

    Dr. Alyson Kelvin is a visiting scientist at VIDO researching COVID-19 since February 2020. Find out how the containment facilities and research collaborations are supporting efforts to develop solutions for the pandemic.

  • Video: Dr. Jason Kindrachuk's COVID-19 research at VIDO

    Dr. Jason Kindrachuk is a visiting scientist at VIDO to advance research against COVID-19. In this video, he explains his expertise in emerging viruses, and why the capabilities of VIDO and its research teams help drive Canada’s pandemic response.

  • Video: Emerging coronavirus research at VIDO

    Dr. Darryl Falzarano and his team are focused on emerging viruses. In this video they describe the development of innovative solutions and the importance of understanding emerging infectious diseases so we are better prepared for future threats.

  • VIDO-InterVac on track to become ‘Canada’s centre for pandemic research’

    A major takeaway from the COVID-19 pandemic is that emerging diseases require rapid responses and Canada needs to be better prepared to respond to the next one.

  • CLC Public Meeting: COVID-19 Vaccine Development

    Watch the recording of the VIDO-InterVac Community Liaison Committee Public Meeting.

  • VIDO-InterVac COVID-19 vaccine to start toxicology studies

    Our work to develop and advance a COVID-19 vaccine candidate has progressed rapidly throughout the summer.

  • Making a difference: USask research centres help to combat COVID-19 pandemic

    Several University of Saskatchewan research centres are supporting the international effort to fight COVID-19 with some of the most advanced research tools Canada has to offer.

  • Uniquely USask: VIDO-InterVac a world-class research facility

    It is one of the largest and most advanced infectious disease research facilities in the world, with unique features that attract scientists from across the country and around the globe.

  • Video: Developing a vaccine for COVID-19

    Research technicians Jocelyne Lew and Shelby Landreth discuss how they are helping to develop a vaccine and test antivirals for COVID-19. They are members of a larger team working to advance solutions for this new virus (SARS-CoV-2).

  • VIDO-InterVac making progress on vaccine

    There are some promising early signs as researchers at the VIDO-InterVac develop a vaccine for COVID-19.

  • VIDO-InterVac team tackles coronavirus: Researchers developing prototype vaccines at USask

    As the world deals with the new pandemic, the novel coronavirus has become the No.1 priority for researchers VIDO-InterVac.

  • Video: Novel Coronavirus Research at VIDO-InterVac

    Dr. Volker Gerdts, director and CEO, discusses ongoing efforts at VIDO-InterVac to develop a vaccine for the novel coronavirus causing COVID-19.